Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 177   

Articles published

BMY 55.60 -0.05 (-0.09%)
price chart
Bridges Investment Management Inc Buys Bristol-Myers Squibb Company, Bristol ...
Bridges Investment Management Inc initiated holdings in Inc. The purchase prices were between $49.69 and $52.94, with an estimated average price of $51.48.
What's in the Offing for Bristol-Myers (BMY) in Q2 Earnings?  Yahoo Finance
Adams Express Co Buys Bristol-Myers Squibb Company, Bristol-Myers Squibb ...
Bristol-Myers Squibb Reports Expanded Approval For Yervoy - Quick Facts
( - Bristol-Myers Squibb Company ( BMY ) announced the U.S. FDA has expanded the indication for Yervoy (ipilimumab) injection for intravenous use to now include the treatment of unresectable or metastatic melanoma in pediatric patients 12 ...
FDA expands indication of Yervoy to include pediatric patients with melanoma  Healio
Horan Capital Management Buys Bristol-Myers Squibb Company, CVS Health Corp ...
Horan Capital Management initiated holdings in Schwab US Aggregate Bond. The purchase prices were between $51.77 and $52.58, with an estimated average price of $52.15.
Ahead Of Earnings: Why You Should Be Buying Merck And Selling Bristol-Myers
Pharmaceutical giants Bristol-Myers Squibb Co (NYSE: BMY) and Merck & Co., Inc. (NYSE: MRK) both release their second quarter earnings reports this week.
US Food and Drug Administration Accepts Bristol-Myers Squibb's ...  Business Wire (press release)
Bristol-Myers Squibb Company (BMY), Avon Products, Inc. (AVP) — Investors ...  Newburgh Gazette
Ex-Dividend Reminder: Bristol-Myers Squibb, Medtronic and Global Net Lease
Looking at the universe of stocks we cover at Dividend Channel , on 7/5/17, Bristol-Myers Squibb Co. (Symbol: BMY), Medtronic PLC (Symbol: MDT), and Global Net Lease Inc (Symbol: GNL) will all trade ex-dividend for their respective upcoming dividends.
Guardian Investment Management Raises Stake in Bristol-Myers Squibb Company ...  Insider Tradings
Bristol-Myers Could Return 40% in Two to Three Years  Barron's
Horan Capital Management Buys Bristol-Myers Squibb Company, CVS Health Corp ...
Hunt Valley, MD, based Investment company Horan Capital Management buys Bristol-Myers Squibb Company, CVS Health Corp, Biogen Inc, Schwab US Aggregate Bond, Schwab U.S.
Could Bristol-Myers Squibb Co. Cure Forum Shopping?
In an 8-1 decision, the Supreme Court appeared to deal a blow to forum shopping last week in Bristol-Myers Squibb Co. v. Superior Court of California, San Francisco County (“BMS”).
Just the Facts on Bristol-Myers Squibb Company (BMY)  StockNewsJournal
Is Bristol-Myers Squibb Company (BMY) a good buy?  Leicester Post
The Game Changes: Is Bristol-Myers Squibb The End Of An Era?
In Bristol-Myers Squibb, the Court ruled that a mass tort brought against the drug company failed to establish specific jurisdiction in California because there was an insufficient link between their claims and that state.
Lookout for Price Target? The Southern Company (SO), Bristol-Myers Squibb ...  StockNewsJournal
What's Real Worth Of McKesson Corporation (MCK), Bristol-Myers Squibb ...  Newburgh Gazette
A Closer Look At Bristol-Myers Squibb's Oncology Business
Cancer drugs (oncology business) account for nearly 60% of Bristol-Myers Squibb's valuation, according to our estimates.
Bristol-Myers Reports Data on Immuno-Oncology Drug Empliciti  Yahoo Finance
Revenue Approximations Analysis: Bristol-Myers Squibb Company (BMY ...  StockNewsJournal
Share Spotlight on Bristol-Myers Squibb Co (BMY) : Technicals in Focus
Shares of Bristol-Myers Squibb Co (BMY) is moving on volatility today 0.07% or $0.04 rom the open. The NYSE listed company saw a recent bid of $55.69 on 2004055 volume.